e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Diagnosis and therapy of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma
Huri Ozkan Yilmaz (Ordu, Turkey), Huri Ozkan Yilmaz, Attila Saygi, Adnan Yilmaz, Dida Marasli, Yeliz Duzgun, Hulya Koksal
Source:
International Congress 2015 – Diagnosis and therapy of lung cancer
Session:
Diagnosis and therapy of lung cancer
Session type:
Thematic Poster Session
Number:
4287
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Huri Ozkan Yilmaz (Ordu, Turkey), Huri Ozkan Yilmaz, Attila Saygi, Adnan Yilmaz, Dida Marasli, Yeliz Duzgun, Hulya Koksal. Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma. Eur Respir J 2015; 46: Suppl. 59, 4287
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Significance of age, tumor location and histological subtype in lung cancer with brain metastasis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Algorithm of preoperative N-staging of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
PET-CT predictors of mediastinal dissemination in lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
General characteristics and therapeutic options in lung cancer in Turkey
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
The prognostic value of D-dimer in lung carcinoma
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Diaphragm invasion worsen the prognosis as indicated in the 8th TNM
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept